| Date | Title | Description |
| 27.02.2026 | SHINE Technologies Secures $240M, Propelling Fusion and Medical Isotopes Forward | SHINE Technologies secured $240 million in new equity funding, pushing its total capital raised beyond $1 billion. Dr. Patrick Soon-Shiong, a noted biotech visionary, joined its Board of Directors. This substantial investment will vigorousl... |
| 26.02.2026 | SHINE Technologies: $240 Million Raised For Nuclear Fusion And Medical Isotope Expansion | SHINE Technologies, a nuclear fusion company, announced it has raised $240 million in equity funding and appointed Dr. Patrick Soon-Shiong, M.D., Executive Chairman of ImmunityBio and founder of NantWorks, to its Board of Directors. The rou... |
| 26.02.2026 | Shine Raises $240M in Funding | Shine Technologies, a Janesville, WI-based nuclear fusion company, raised $240M in equity funding.
The round was led by NantWorks with additional participation from Fidelity Management and Research Company, Sumitomo Corporation of Americas,... |
| 14.01.2026 | NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF | NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Kristen Sch... |
| 24.01.2022 | Government looks to science, innovation to rejig economy | President Cyril Ramaphosa and Dr Patrick Soon-Shiong at the opening of the NantSA vaccine manufacturing facility in Cape Town. (Image source: GCIS)
President Cyril Ramaphosa says science and innovation are playing a far more prominent role ... |
| 07.09.2018 |
NantWorks Invests In Daybreak Game Company
| Los Angeles-based NantWorks, the investment arm of billionaire Dr. Patrick Soon Shiong, said on Thursday afternoon that it has made a strategic investment in San Diego-based multiplayer online games developer Daybreak Game Company. Size of ... |
| 04.06.2017 | Can Patrick Soon-Shiong silence his many critics? | When asked whether he was overstepping the boundaries by marketing an experimental cancer therapy, Soon-Shiong didn’t miss a beat.
“Look, just so you know; I’ve been working with the FDA for 15 years,” he said. “I’m completely aware of the ... |
| 02.11.2016 |
NantWorks Backs Genos Research
| Culver City-based NantWorks, the collection of companies run by biotech billionaire Patrick Soon Shiong, has backed gene sequencing startup Genos Research, the companies disclosed today. Genos said it raised $6M in the funding round from Na... |
| 22.01.2016 | Soon-Shiong immuno-oncology startup NantCell rakes in $57M | In March, it teamed up with San Diego-based Sorrento Therapeutics – acquiring a next-gen version of Abraxane in a deal worth up to $1.3 billion. About $100 million of that was paid as NantCell Equity.
The company’s had two notable fundraise... |
| 19.10.2015 | Soon-Shiong’s NantWorks invests $50M in Precision Biologics | “Based on a proprietary library of cancer vaccines, antigens and antibodies, the company has developed a portfolio of truly unique antibody therapies, which activate an immune response that are tumor and disease specific,” Soon-Shiong said ... |
| 09.07.2015 |
NantBioScience, Sorrento Therapeutics Launch $100M JV
| Los Angeles-based NantBioScience and San Diego-based Sorrento Therapeutics announced this morning that the two have launched a new, joint venture, aimed at small molecule treatments for cancer. The two said they will invest $100M in the new... |
| 01.07.2015 |
NantHealth Raises $200M From Allscripts
| Los Angeles-based NantHealth, one of the life sciences companies that is part of billionaire Patrick Soon-Shiong's NantWorks, has scored $200M in an investment from Allscripts, the two said Tuesday. According to the two companies, the inves... |
| 30.06.2015 | Allscripts invests $200M in Soon-Shiong’s NantHealth in software integration deal (updated) | The Los Angeles Times reported that the cross-investment, which values Culver City, Calif.-based NantHealth at $2 billion, closer to a planned initial public offering later this year. “We feel we have one or two transactions to accomplish, ... |
| 23.06.2015 |
NantCell Buys VivaBioCell, Backed By $75M In New Funding
| Los Angeles-based NantCell, one of the companies that is part of Dr. Patrick Soon-Shiong's NantWorks, said today that it has acquired an Italian company, VivaBioCell SpA. Financial terms of the deal wer enott disclosed. VivaBioCell is based... |
| 23.06.2015 | Five conspicuous omissions from MIT Tech Review’s 50 smartest companies | …we did not have trouble finding big ideas. To make the list, a company must have truly innovative technology and a business model that is both practical and ambitious, with the result that it has set the agenda in its field over the past 1... |
| 16.05.2015 | From Bigfoot Biomedical’s artificial pancreas to the athenahealth accelerator: 5 must-read stories from MedCity News this week | Bigfoot Biomedical, known best for its grassroots approach to building an artificial pancreas for Type 1 diabetes, is emerging from hacker mode and raising some capital. The startup just brought in a $3.5 million bridge convertible note, an... |
| 12.05.2015 | Soon-Shiong’s NantWorks Unit Gets $100 Million Infusion | - |
| 16.12.2014 |
Sorrento Therapeutics Gets Strategic Investment From NantWorks
| San Diego-based oncology drug developer Sorrento Therapeutics has scored a strategic investment from NantWorks, the biotech research company led by Dr. Patrick Soon-Shiong. According to the two, the investment comes as part of a global, str... |
| 31.10.2014 | Patrick Soon-Shiong startup gets $25M in personalized medicine space | NantWorks hasn’t much discussed what NantBioscience is up to – just that it’s all about “discovering knowledge at the protein level to develop drugs in pursuit of personalized medicine.”
But NantBioscience partnered with University of Color... |
| 31.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $33 million in equity raised, closing out a $48 million Series E round
The funding will bring Aileron candidate ALRN-6924 – a drug that works to activate a solid tumor suppressor protein called p53 – to clinical trial. The company says its ... |
| 13.10.2014 | Phoenix Children’s, Soon-Shiong launching genomic data supercomputer | Soon-Shiong is the founder of Nantworks, largely dedicated to applying genomic and proteomic analysis studies to translate diagnoses and cures more quickly and accurately. So far, his efforts have been focused on the adult population.
Essen... |
| 01.10.2014 | NantHealth Completes $320M Series B Equity Investment and Expands Leadership Team with Healthcare Industry Veterans | Sovereign Wealth Fund, Kuwait Investment Authority Invests $250M and Joins Verizon, Celgene, Blackberry and Blackstone as Strategic Investors in NantHealth
LOS ANGELES–(BUSINESS WIRE)–October 1, 2014–
NantHealth, a NantWorks company that is... |
| 25.10.2012 | NantHealth Receives Investment from Verizon | NantHealth LLC, a Los Angeles, CA-based company focused on delivering next-generation care, has received an equity investment from Verizon Investments LLC, a subsidiary of Verizon Communications.
The amount of the funding was not disclosed.... |
| 01.10.2012 |
JAKKS Pacific, NantWorks In Toy Joint Venture
| Los Angeles-based NantWorks, the technology incubation and investment firm run by billionaire Patrick Soon-Shiong, and Malibu-based toy firm JAKKS Pacific announced this morning that the two are in a join venture to create anew company, Dre... |
| 25.07.2012 | NantPharma Receives US$125M Investment from Blackstone | NantPharma, a California-based NantWorks company whose products include high quality, biologically derived pharmaceuticals, has received a US$125m investment from Blackstone (NYSE: BX).
In conjunction with the transaction, Chinh E. Chu and ... |
| 25.07.2012 |
NantPharma Gets $125M From Blackstone
| Los angeles-based NantWorks, the technology thinktank of Los Angeles billionaire Dr. Patrick Soon-Shiong, said Tuesday that one of its companies, NantPharma, has received $125M in an investment by private equity firm Blackstone. NantPharma ... |
| 28.03.2012 | DNA testing system to prevent cancer diagnosis errors lands $30M series A | Michael Harmon, director of marketing and public relations for Know Error, said that more than 1 percent of the 20,000 DNA-matching tests the company has done so far have resulted in a nonmatch report, which means the biopsy was either cont... |
| 28.03.2012 | Strand Diagnostics to Receive up to $30M in Funding over Three Years | Strand Diagnostics, LLC, an Indianapolis, IN-based maker of a system that uses bar coding, forensic chain-of-custody principles, and DNA testing to complete the diagnostic testing cycle before initiating treatment, will receive up to $30m i... |
| 28.03.2012 |
Strand Diagnostics Raises $30 Million From NantWorks
| Los Angeles-based NantWorks, the business investment and development firm run by billionaire Patrick Soon-Shiong, has invested $30M in Strand Diagnostics, a developer of a diagnostic and DNA testing service for diagnosing cancer. According ... |
| - | DNA testing system to prevent cancer diagnosis errors lands $30M series A | Indianapolis DNA testing company Strand Diagnostics LLC has secured $30 million in series A funding to accelerate its growth, scale its operations infrastructure and expand its sales and marketing efforts.
Strand’s Know Error system aims to... |
| - | Can Patrick Soon-Shiong silence his many critics? | On the phone, Patrick Soon-Shiong speaks slowly and deliberately. He clearly trusts himself, but he doesn’t trust journalists anymore.
A series of scathing articles by STAT News and Politico sent stocks in his publicly-traded companies tumb... |
| - | Five conspicuous omissions from MIT Tech Review’s 50 smartest companies | We know who made the cut in the latest MIT Technology Review list of the 50 Smartest Companies of 2015.
But there were a few conspicuous omissions – take Theranos, for instance, or Alexion Pharmaceuticals – from the otherwise meaty list of ... |
| - | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC. Here are the new funding notices fro... |
| - | Phoenix Children’s, Soon-Shiong launching genomic data supercomputer | Phoenix Children’s Hospital, with the help of a billionaire physician, is launching the Chan Soon-Shiong Children’s Precision Medicine Institute, which will include a cloud-based super computer that lets physicians utilize genome data that ... |
| - | Soon-Shiong immuno-oncology startup NantCell rakes in $57M | NantCell, the immuno-oncology arm of Dr. Patrick Soon-Shiong’s sprawling NantWorks umbrella company, has just raised another $57 million, according to a regulatory filing. There are 125 investors listed on this equity raise.
NantCell was la... |
| - | Patrick Soon-Shiong startup gets $25M in personalized medicine space | NantBioscience – the personalized medicine subsection of the extraordinarily funded Patrick Soon-Shiong-led startup NantWorks – reported in SEC filings that it’s raised $25 million.
This comes soon after the umbrella company’s announcement ... |
| - | Allscripts invests $200M in Soon-Shiong’s NantHealth in software integration deal (updated) | Electronic health records vendor Allscripts Healthcare Solutions has bought a 10 percent equity stake in NantHealth, the health IT arm of Dr. Patrick Soon-Shiong’s empire, for $200 million, while another Soon-Shiong company has bought $100 ... |
| - | From Bigfoot Biomedical’s artificial pancreas to the athenahealth accelerator: 5 must-read stories from MedCity News this week | On MedHeads Friday, we covered everything from Dr. Patrick Soon-Shiong’s continued funding for NantBioscience, our site’s exciting new redesign and other trends from the week. Watch the broadcast above, but also review five of the more impo... |
| - | Soon-Shiong’s NantWorks invests $50M in Precision Biologics | Patrick Soon-Shiong mega-startup NantWorks just bought out a majority stake in immunotherapy startup Precision Biologics with a $50 million investment.
The Maryland precision medicine biotech is developing a monoclonal antibody approach and... |
